Cardiac Donor Risk Factors Predictive of Short-Term Heart Transplant Recipient Mortality: An Analysis of the United

R A Sorabella1, L Guglielmetti1, A Kantor1

  • 1Division of Cardiothoracic Surgery, New York Presbyterian Hospital, Columbia University College of Physicians and Surgeons, New York, New York, USA.

Transplantation Proceedings
|December 29, 2015
PubMed

Insights

Older donor age and longer graft ischemic times increase heart transplant recipient risk. Conversely, male donors and the use of antihypertensive agents or insulin show protective effects on 1-year outcomes.

Area of Science:

  • Cardiology
  • Transplantation Medicine
  • Organ Donation

Background:

  • Addressing donor heart shortages necessitates evaluating expanded donor criteria.
  • The United Network for Organ Sharing (UNOS) database offers insights into donor characteristics and recipient outcomes.

Purpose of the Study:

  • To assess the impact of cardiac donor characteristics on post-heart transplantation recipient survival.
  • Identify specific donor factors influencing 1-year recipient outcomes.

Main Methods:

  • Retrospective analysis of adult heart transplant recipients (2004-2012) from the UNOS STAR database.
  • Stratification into survivors (n=13,643) and non-survivors/retransplanted (n=1785) at 1 year.
  • Multivariable logistic regression analysis of 33 donor variables to predict 1-year mortality or retransplantation.

Main Results:

  • Overall 1-year survival was 88.4%.
  • Donor age >40 years, graft ischemic time >3 hours, and specific cardioplegia solutions (Celsior) predicted adverse outcomes.
  • Male donor sex, antihypertensive agents, and insulin administration were associated with improved 1-year survival.

Conclusions:

  • Donor age, graft ischemic time, and preservation solution impact short-term heart transplant success.
  • Donor management strategies involving antihypertensives and insulin may offer protective benefits for recipients.
Abstract

Related Concept Videos

Tissue Transplantation01:24

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
1.2K
Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
686
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
769